Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3176-70-3

Post Buying Request

3176-70-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3176-70-3 Usage

General Description

1H-Benzimidazole-2-methanethiol, alpha-methyl-(9CI) is a chemical compound with a molecular formula C9H9NS. It is a derivative of benzimidazole and contains a sulfur atom. 1H-Benzimidazole-2-methanethiol,alpha-methyl-(9CI) is also known as 2-Methylbenzimidazol-1-yl methane thiol. It is used in organic synthesis and pharmaceutical research as a building block for the synthesis of various organic compounds. It has potential applications in drug development and as a reagent in chemical reactions. The alpha-methyl substitution on the benzimidazole ring adds specific properties to this compound, making it an important chemical in many research and industrial applications.

Check Digit Verification of cas no

The CAS Registry Mumber 3176-70-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,7 and 6 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 3176-70:
(6*3)+(5*1)+(4*7)+(3*6)+(2*7)+(1*0)=83
83 % 10 = 3
So 3176-70-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2S/c1-6(12)9-10-7-4-2-3-5-8(7)11-9/h2-6,12H,1H3,(H,10,11)

3176-70-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(1H-benzimidazol-2-yl)ethanethiol

1.2 Other means of identification

Product number -
Other names 2-(1-mercaptoethyl)benzimidazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3176-70-3 SDS

3176-70-3Relevant articles and documents

The design and synthesis of potent benzimidazole derivatives via scaffold hybridization and evaluating their antiproliferative and proapoptotic activity against breast and lung cancer cell lines

Elgawish, Mohamed Saleh,Ghareb, Nagat,Nafie, Mohamed S.,Yamada, Koji,Yassen, Asmaa S. A.

, p. 4239 - 4256 (2022/03/14)

One of the current approaches used in drug discovery and development is the synthesis of novel small compounds from existing structural motifs via molecular hybridization. In the current study, a new series of benzimidazo[1,5-a]imidazole, benzimidazo[1,2-c]thiazole, benzimidazotriazine, and benzimidazo[1,2-c]quinazoline scaffolds was synthesized via C-H cycloamination, using a metal-free synthetic pathway, as potent antiproliferative antiangiogenic molecules against breast (MCF-7) and lung (A549) cancer cell lines. The expansion of the benzimidazole scaffold with heterocyclic rings resulted in a tridentate cyclic system that occupied the ATP-binding site and neighboring hydrophobic pocket, eliciting promising affinity and selectivity toward VEGFR2 through extra H-bonding and completely occupying the entrance region. Molecular docking studies demonstrated that most of the designed compounds bind VEGFR-2 adopting a DFG-in conformation, where the benzimidazole scaffold occupied the hinge region, the central aromatic ring occupied hydrophobic region I adjacent to the hinge region, and the hydrogen bond donor/acceptor bound to the hydrogen-bond-rich region. In comparison to lenvatinib, which had a docking score of-12.47 kJ mol-1 and a Glide E-model value of-132.68 kcal mol-1, compound 17 had a decent docking score of-8.95 kJ mol-1 and a Glide E-model value of-92.17 kcal mol-1. The designed molecules exhibited promising in situ cytotoxic activities, with IC50 values ranging from 9.2 to 42.3 μM against MCF-7 and A549, comparable to 5-fluorouracil (which has IC50 values of 10.32 and 5.8 μM against MCF-7 and A549, respectively); they also showed selective in vitro inhibitory activity against VEGFR2 when compared with other designed kinases, with compound 17 showing an IC50 value (23 nM) as good as that of sorafenib (30 nM). Flow cytometry and cell cycle assays revealed that apoptotic cell death induction occurred in the A549 cell line through the activation of certain caspases and the tumor suppressor P53 and through repressing the generation of BAX and PUMA. Furthermore, the proposed compounds exhibited physicochemical and pharmacokinetics properties within the acceptable range for human usage, as anticipated by an in silico ADME study, making them lead molecules for developing new forms of medication.

Synthesis and structural features of new cyclofunctionalized benzimidazoles

Chimirri, Alba,Monforte, Anna Maria,Monforte, Pietro,Nicolo, Francesco,Rao, Angela,Zappala, Maria

, p. 613 - 620 (2007/10/03)

The synthesis of new tricyclic derivatives having sulfur-containing six or seven-membered rings fused to the > edge of benzimidazole system, is reported. The stereochemical characteristics of thiazino- and thiazepinobenzimidazoles (4-7) are described

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3176-70-3